[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
Crohn's Disease |
Crohn's disease; Crohn//'s disease; Inflamatory Bowel Disease; Inflammatory Bowel Disease, Crohn's |
Clinical Trial: Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects with Crohn's Disease
This study is currently recruiting patients.
|
Purpose
The goal of this study is to test whether adalimumab can induce clinical remission in subjects with active Crohn's disease who have been initially treated with infliximab and either lost response or discontinued its use as a result of intolerance to the drug.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Crohn's Disease | Drug: Adalimumab | Phase III |
MedlinePlus related topics: Crohn's Disease
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control
Official Title: A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects with Moderate to Severe Crohn's Disease who Have Lost Response or are Intolerant to Infliximab
Expected Total Enrollment: 300
Study start: October 2004
Eligibility
Ages Eligible for Study: 18 Years - 75 Years, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- Males and females between the ages of 18 and 75 who are diagnosed with mild to moderate Crohn's disease (defined by a CDAI [Crohn's Disease Activity Index] score of 220 and 450)
- Normal lab parameters
- Are willing to give informed consent
- Have previously used and either were intolerant to or lost response to infliximab
Exclusion Criteria:
- History of certain types of cancer
- Diagnosis of ulcerative colitis
- Pregnant female or breast feeding subjects
- Known obstructive strictures
- Surgical bowel resection in the past 6 months
- History of listeria, human immunodeficiency virus (HIV), central nervous system demyelinating disease or untreated TB (tuberculosis)
- History of poorly controlled medical conditions
- Specific doses and durations of Crohn's medications
- Subjects that have previously used infliximab and have never clinically responded unless primary non-response was due to a treatment limiting reaction to infliximab
Location and Contact Information
Alabama
Clinical Research Associates, Huntsville, Alabama, 35801, United States; Recruiting
Allen Goetsch, MD, Principal Investigator
California
Medical Associates Research Group, San Diego, California, 92123, United States; Recruiting
Michael Bennett, MD, Principal Investigator
Sharp Rees-Stealy Medical Group, San Diego, California, 92123, United States; Recruiting
Bruce R Johnson, MD, Principal Investigator
Capitol Gastroenterology Consultants Medical Group, Inc., Roseville, California, 95661, United States; Recruiting
Theodor Feinstat, MD, Principal Investigator
Colorado
SMC-Trauma Research, Englewood, Colorado, 80113, United States; Recruiting
Lawrence Kim, MD, Principal Investigator
Florida
Borland-Groover Clinic, Jacksonville, Florida, 32256, United States; Recruiting
Lawrence Goldberg, MD, Principal Investigator
Shafran Gastroenterology Center, Winter Park, Florida, 32789, United States; Recruiting
Ira Shafran, MD, Principal Investigator
V.A. Medical Center, Gainesville, Florida, 32608, United States; Recruiting
John Valentine, MD, Principal Investigator
Clinical Research of West Florida, Inc, Clearwater, Florida, 33765, United States; Recruiting
Michael Weiss, MD, Principal Investigator
Georgia
Pinnacle Trials, Inc., Atlanta, Georgia, 30329, United States; Terminated
Atlanta Gastroenterology Assoc., Atlanta, Georgia, 30342, United States; Not yet recruiting
Douglas C. Wolf, MD, Principal Investigator
Illinois
Ntouch Research, Peoria, Illinois, 60602, United States; Recruiting
Ben Dolin, MD, Principal Investigator
The University of Chicago, Chicago, Illinois, 60673, United States; Recruiting
Stephen B Hanauer, MD, Principal Investigator
Indiana
Outpatient Clinical Research Facility University of Indianapolis, Indianapolis, Indiana, 462025250, United States; Not yet recruiting
Debra J Helper, MD, Principal Investigator
Kentucky
University of Kentucky Medical Center Division of Digestive Diseases, Lexington, Kentucky, 40536, United States; Recruiting
Willem de Villiers, MD, Principal Investigator
Louisiana
Drug Research Services, Inc., Metairie, Louisiana, 70001, United States; Recruiting
David R Silvers, MD, Principal Investigator
Maryland
Chevy Chase Clinical Research, Chevy Chase, Maryland, 20815, United States; Recruiting
Robert Hardi, MD, Principal Investigator
Charm City Research, Towson, Maryland, 21204, United States; Recruiting
James Novick, MD, Principal Investigator
Minnesota
Mayo Clinic Research, Rochester, Minnesota, 559050002, United States; Recruiting
William Sandborn, MD, Principal Investigator
Minnesota Gastroenterology P.A., Plymouth, Minnesota, 55446, United States; Not yet recruiting
Robert McCabe, MD, Principal Investigator
Mississippi
Gastrointestinal Associated, P.A., Jackson, Mississippi, 39202, United States; Recruiting
Billy Long, MD, Principal Investigator
Missouri
St. Louis Center for Clinical Research, St. Louis, Missouri, 63128, United States; Recruiting
James Dimitroff, MD, Principal Investigator
Glen Gordon, MD, Mexico, Missouri, 65265, United States; Recruiting
Glenn Gordon, MD, Principal Investigator
New Jersey
Atlantic Gastroenterology Associates, LLC, Egg Harbor Township, New Jersey, 08234, United States; Recruiting
Barry Kaufman, MD, Principal Investigator
New York
NY Center for Clinical Research, Lake Success, New York, 11042, United States; Recruiting
David Eskreis, MD, Principal Investigator
Long Island Clinical Research Assoc. LLP, Great Neck, New York, 11021, United States; Not yet recruiting
Seymour Katz, MD, Principal Investigator
North Carolina
Wake Research Associates, Raleigh, North Carolina, 27612, United States; Recruiting
Charles Barish, MD, Principal Investigator
Asheville Gastroenterology Associates, Ashville, North Carolina, 28801, United States; Recruiting
William R Harlan, MD, Principal Investigator
Ohio
Gastroenterology Associates of Cleveland, Mayfield Heights, Ohio, 44124, United States; Recruiting
Dianne Himmelman 440-442-6173 research@gastro-associates.com
Michael Frankel, MD, Principal Investigator
Gastrointestinal and Liver Disease Consultants, Dayton, Ohio, 45440, United States; Recruiting
Donald Lutter, MD, Principal Investigator
Consultants for Clinical Research, Cincinnati, Ohio, 45219, United States; Not yet recruiting
Alan V Safdi, MD, Principal Investigator
Cleveland Clinic Foundation, Cleveland, Ohio, 44195, United States; Not yet recruiting
Bret Lashner, MD, Principal Investigator
Oregon
The Oregon Clinic, PC Gastroenterology Division, Portland, Oregon, 97220, United States; Recruiting
Phillip K Kiyasu, Md, Principal Investigator
Pennsylvania
Regional Gastroenterologist Associates of Lancaster, Lancaster, Pennsylvania, 17604, United States; Terminated
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, 15261, United States; Recruiting
Miguel Regueiro, MD, Principal Investigator
South Carolina
Columbia Gastro Associates, Columbia, South Carolina, 29204, United States; Recruiting
John Popp, MD, Principal Investigator
Tennessee
Gastrointestinal Associates, Knoxville, Tennessee, 37909, United States; Recruiting
John Haydek, MD, Principal Investigator
Vanderbilt University Medical Center, Nashville, Tennessee, 37232, United States; Not yet recruiting
David Schwartz, MD, Principal Investigator
Gastroenterology Center of the Mid South, Memphis, Tennessee, 38120, United States; Recruiting
Zaid Younes, MD, Principal Investigator
Texas
Austin Gastroenterology, Austin, Texas, 78745, United States; Recruiting
William Stassen, MD, Principal Investigator
Utah
Wasatch Clinical Research, Salt Lake City, Utah, 84107, United States; Not yet recruiting
P J. Pederson, M.D., Principal Investigator
Virginia
Digestive and Liver Disease, Norfolk, Virginia, 23205, United States; Recruiting
Internal Medicine Associates, Danville, Virginia, 25451, United States; Recruiting
Jack Bryan Spainhour, MD, Principal Investigator
Washington
Spokane Digestive Disease Center, Spokane, Washington, 99204, United States; Recruiting
Karl Houglum, MD, Principal Investigator
Wisconsin
Discovery Research International, LLC, Milwaukee, Wisconsin, 53207, United States; Recruiting
David Dozer, MD, Principal Investigator
More Information
Record last reviewed: March 2005
Last Updated: March 29, 2005
Record first received: March 11, 2005
ClinicalTrials.gov Identifier: NCT00105300
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Not Signed In -


